NL-OMON52291招募中不适用
Atypical parkinsonism: Early diagnosis with quantitative MRI - APqMRI
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •- Patients who present at the outpatient clinic of the department of neurology
- •with symptoms consistent with degenerative parkinsonism.
- •- For possible PD patients: Diagnosis of Parkinson*s disease is unclear and an
- •atypical form of parkinsonism is suspected.
- •- For near-certain PD patients: Patients for whom Parkinson*s disease is highly
- •- At least 50 years old
- •- Signed informed consent.
- •Healthy volunteers:
- •- Healthy subject (defined as a volunteer without and signs or symptoms of
- •- At least 50 years old and not older than 75
- •- Signed informed consent
排除标准
- •- Patients with parkinsonism symptoms caused by medication or essential
- •In addition, both patients and healthy volunteers are excluded if they meet any
- •of the following criteria:
- •- a history of another neurodegenerative disease.
- •- History of significant intracranial disease
- •- Contra-indication to an MRI exam
- •- Metal implants
- •- Women who are pregnant or lactating
- •- Having any physical or mental status that interferes with the informed
- •consent procedure
研究者
相似试验
招募中
不适用
Prospective study on early diagnosis of Parkinson's disease in medical checkup examinees with non-motor symptomsParkinson's disease Dementia with Lewy BodiesJPRN-UMIN000030396agoya University, Department of Neurology60
招募中
不适用
Differential diagnostics in Parkinsons Disease and the Atypical Parkinsonian Disorders10028037Parkinson's DiseaseNL-OMON32744niversitair Medisch Centrum Sint Radboud150
已完成
不适用
DiPAR: Diagnosing Parkinson*s Disease by neuromuscular function evaluatioParkinson's diseasemovement disorders10028037NL-OMON38380niversitair Medisch Centrum Groningen90
已完成
不适用
Quantification of Parkinson*s Disease motor symptoms using the PowerGloveParkinson's disease10028037PDNL-OMON40878Academisch Medisch Centrum35
已完成
不适用
A Phase 0 biomarker study in patients with Parkinson*s Disease and healthy controlsParkinson's diseaseNL-OMON46465Denali Therapeutics Inc.35
